// App-Quantinova.ai

1289 : Renal cell carcinoma patients have altered HLA expression patterns which show correlations to clinical parameter

Researchers

Presenter

  • Steffen Goebel

Principal Investigators

  • Karen Bluemke-Anbau

  • Wolfgang Altermann

  • Udo Bilkenroth

  • Axel Meye

  • Susanne Fuessel

  • Astrid Kehlen

  • Christine Lautenschlaeger

  • Andres Melchior

  • Paolo Fornara

  • Helge Taubert

Medical Centers

  • Technical University Dresden, Dresden, Germany

  • University Halle, Halle, Germany

  • Urological Practice Seepark, Salzmuende, Germany

  • University of Erlangen-Nuernberg, Erlangen, Germany

  • Medical Laboratory East-Saxony, Dresden, Germany

  • Hospital of Eisleben, Eisleben, Germany

Locations

  • Germany

Companies

  • Probiodrug AG

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Renal cell carcinoma

Biomarkers

  • Circulating tumor cells

  • Cluster of differentiation 45

  • Major histocompatibility complex, class II, DR beta 1

  • X-Ray Repair Cross Complementing 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved